Latest News

Cyclone Helene effect on Baxter to additional limit IV fluid supply, HHS says

The closure of Baxter International's. North Cove facility in North Carolina following. Typhoon Helene could further restrict the supply of intravenous. fluids, the U.S. Department of Health and Person Services said on. Wednesday.

The business, among the 4 main U.S. suppliers of IV. fluids, had on Sept. 29 stated production at the website has been. shut due to flooding. It added it was working with the. government to assess the damage and bring the plant back online.

On Tuesday, the U.S Food and Drug Administration stated 2. dosages of Baxter's Dextrose services for low blood glucose and a. saline option are in shortage.

Meanwhile, HHS stated it has likewise considered the possibility. of Hurricane Milton further interrupting the IV fluid supply chain. and was working to move the product far from the predicted course. of the storm.

Baxter has said it intends to restart production in phases and. go back to 90% to 100% allotment of specific IV options by the. end of 2024.

The company stated it was also increasing the U.S. allotment. of its greatest demand IV fluids for direct customers to 60% from. 40% and for distributors to 60% from 10%, effective Oct. 9.

Germany's Fresenius stated on Tuesday it was. examining choices to start new infusion-solution assembly line. faster than prepared at a North Carolina facility to help. reduce the potential scarcities.

The U.S. health department stated it is working with other. domestic IV services makers to combat the supply crunch.

(source: Reuters)